XML 46 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
The Company recorded stock-based compensation expense in the following expense categories of its accompanying audited statements of operations and comprehensive loss (amounts in thousands):
Year Ended December 31,
20212020
Research and development$2,200 $531 
General and administrative3,267 735 
Total stock-based compensation$5,467 $1,266 
Schedule of option activity
The following table summarizes option activity under the 2020 Plan and the 2016 Stock Incentive Plan:
Options
Weighted
Average
Exercise Price
Weighted
Average
Remaining Life
(Years)
Balance at January 1, 20212,742,022 $7.95 8.82
Granted325,671 23.60 
Exercised(557,609)3.40 
Forfeited(61,408)12.13 
Balance at December 31, 20212,448,676 $10.96 8.08
Vested and expected to vest2,418,923 $10.88 8.07
Exercisable at the end of the period1,259,440 $6.44 7.55
Schedule of valuation assumptions
The grant-date fair value of options granted under the Company’s 2020 Plan were estimated throughout the year using the Black-Scholes option-pricing model using the following weighted-average assumptions:
Year Ended December 31,
20212020
Expected term - years6.085.94
Expected volatility81.4 %75.3 %
Risk-free interest rate1.1 %0.5 %
Expected dividends— — 
The grant-date fair value of shares issued under the Company’s 2020 ESPP were estimated throughout the year using the Black-Scholes option-pricing model using the following weighted-average assumptions:
Year Ended December 31,
20212020
Expected term - years0.500.00
Expected volatility81.3 %— %
Risk-free interest rate0.9 %— %
Expected dividends— — 
Schedule of restricted stock activity
The following table summarizes the activity relating to these shares:
Awards
Outstanding at December 31, 202011,752 
Vested(11,752)
Outstanding at December 31, 2021—